These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15149158)

  • 1. Expression of survivin, bcl-2, P53 and bax in breast carcinoma and ductal intraepithelial neoplasia (DIN 1a).
    Kayaselcuk F; Nursal TZ; Polat A; Noyan T; Yildirim S; Tarim A; Seydaoglu G
    J Exp Clin Cancer Res; 2004 Mar; 23(1):105-12. PubMed ID: 15149158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
    Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
    Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivin expression in breast carcinoma: correlation with apoptosis and prognosis.
    Nassar A; Sexton D; Cotsonis G; Cohen C
    Appl Immunohistochem Mol Morphol; 2008 May; 16(3):221-6. PubMed ID: 18301249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between the expression of apoptosis-related bcl-2 and p53 oncoproteins and the carcinogenesis and progression of breast carcinomas.
    Zhang GJ; Kimijima I; Abe R; Kanno M; Katagata N; Hara K; Watanabe T; Tsuchiya A
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2329-35. PubMed ID: 9815631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations in survivin expression with the expression of p53 and bcl-2 in invasive ductal carcinoma of the breast.
    Al-Joudi FS; Iskandar ZA; Imran AK
    Southeast Asian J Trop Med Public Health; 2007 Sep; 38(5):904-10. PubMed ID: 18041310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of Bcl-2 protein in breast lesions: correlation with Bax, p53, Rb, C-erbB-2, EGFR and proliferation indices.
    Ioachim EE; Malamou-Mitsi V; Kamina SA; Goussia AC; Agnantis NJ
    Anticancer Res; 2000; 20(6B):4221-5. PubMed ID: 11205251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological study of intraductal papillary mucinous tumor of the pancreas: special reference to the roles of Survivin and p53 in tumorigenesis of IPMT.
    Jinfeng M; Kimura W; Sakurai F; Moriya T; Takeshita A; Hirai I
    Int J Gastrointest Cancer; 2002; 32(2-3):73-81. PubMed ID: 12794243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. bcl-2 expression in the spectrum of preinvasive breast lesions.
    Siziopikou KP; Prioleau JE; Harris JR; Schnitt SJ
    Cancer; 1996 Feb; 77(3):499-506. PubMed ID: 8630957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma.
    Lee WY; Jin YT; Tzeng CC
    Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
    Vasaturo F; Sallusti E; Gradilone A; Malacrino C; Nardo T; Avagnano G; Aglianò AM; Granato T; De Vincenzi B; Coppotelli G; Marzullo A; Soda G; Simonelli L; Modesti M; Scarpa S
    Int J Oncol; 2005 Oct; 27(4):1005-11. PubMed ID: 16142317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different proliferative patterns characterize different preinvasive breast lesions.
    Viacava P; Naccarato AG; Bevilacqua G
    J Pathol; 1999 Jul; 188(3):245-51. PubMed ID: 10419590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAG-1 expression correlates with Bcl-2, p53, differentiation, estrogen and progesterone receptors in invasive breast carcinoma.
    Tang SC; Beck J; Murphy S; Chernenko G; Robb D; Watson P; Khalifa M
    Breast Cancer Res Treat; 2004 Apr; 84(3):203-13. PubMed ID: 15026618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel antiapoptosis gene, survivin, bcl-2, p53 expression in cervical carcinomas].
    Wang M; Wang B; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2001 Sep; 36(9):546-8. PubMed ID: 11769670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer.
    Linjawi A; Kontogiannea M; Halwani F; Edwardes M; Meterissian S
    J Am Coll Surg; 2004 Jan; 198(1):83-90. PubMed ID: 14698315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
    Diaz N; Minton S; Cox C; Bowman T; Gritsko T; Garcia R; Eweis I; Wloch M; Livingston S; Seijo E; Cantor A; Lee JH; Beam CA; Sullivan D; Jove R; Muro-Cacho CA
    Clin Cancer Res; 2006 Jan; 12(1):20-8. PubMed ID: 16397019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The expression of bcl-2, P53 and c-erbB-2 onco-proteins in breast cancer and their clinicopathological significance].
    Gao L; Ding H; Deng Y
    Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):165-8. PubMed ID: 9275673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
    Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
    J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas.
    Tanaka K; Iwamoto S; Gon G; Nohara T; Iwamoto M; Tanigawa N
    Clin Cancer Res; 2000 Jan; 6(1):127-34. PubMed ID: 10656440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.